2C-G Stats & Data

• Active oral range is reported as 20–35 mg with 18–30 h duration in the original PiHKAL entry; this unusually long span increases risks of fatigue, sleep loss, and decision-making lapses late in the experience, so plan a 36–48 h recovery window and avoid redosing. • Onset can be slow; some G-series compounds reach full intensity 2–3 h after dosing. Redosing before 3 h risks accidental over-intoxication. • Users and Shulgin’s own notes describe relatively mild visual phenomena and a clearer, more stimulating headspace compared to other 2C-x, with occasional appetite suppression; stimulation without strong visuals can still produce anxiety, tachycardia, and vasoconstriction. • Because the active range is low tens of milligrams, accurate weighing is essential; use a calibrated 0.001 g scale or volumetric dosing to prevent dangerous overshoot. • Avoid insufflation: other 2C-x phenethylamines cause severe nasal irritation and unpredictable potency when snorted; oral is the established route for 2C-G. • Do not combine with MAOIs (including harmala alkaloids); MAO inhibition can markedly and unpredictably potentiate psychedelics. • Combining with other stimulants (including high caffeine doses) increases cardiovascular strain and anxiety; keep caffeine typical dietary or lower, and avoid amphetamines. • If an experience becomes overwhelming, non-pharmacological de-escalation (reassurance, quiet space, hydration) is first-line; in a true crisis, benzodiazepines can be used by a sober sitter or medical professional, but repeated benzo use carries tolerance and dependence risks and should not be routine. • 2C-G has been scarce; recent market appearances have included inconsistent labeling and premixed capsules that prevent accurate dose control. Use a lab-based drug checking service when possible; reagent results for 2C-G are not well characterized. • People with cardiovascular disease, uncontrolled hypertension, severe anxiety, or sleep disorders should avoid 2C-G due to its long stimulation window and potential for insomnia. • Legal status varies; synthesis, possession, or distribution may be illegal in many jurisdictions.